246 related articles for article (PubMed ID: 17640041)
1. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration.
Cui Y; Hosui A; Sun R; Shen K; Gavrilova O; Chen W; Cam MC; Gao B; Robinson GW; Hennighausen L
Hepatology; 2007 Aug; 46(2):504-13. PubMed ID: 17640041
[TBL] [Abstract][Full Text] [Related]
2. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
[TBL] [Abstract][Full Text] [Related]
3. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism.
Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ
Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450
[TBL] [Abstract][Full Text] [Related]
4. STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice.
Sun R; Park O; Horiguchi N; Kulkarni S; Jeong WI; Sun HY; Radaeva S; Gao B
Hepatology; 2006 Oct; 44(4):955-66. PubMed ID: 17006930
[TBL] [Abstract][Full Text] [Related]
5. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
[TBL] [Abstract][Full Text] [Related]
6. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells.
Ooi GT; Hurst KR; Poy MN; Rechler MM; Boisclair YR
Mol Endocrinol; 1998 May; 12(5):675-87. PubMed ID: 9605930
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
9. Genomic dissection of the cytokine-controlled STAT5 signaling network in liver.
Hosui A; Hennighausen L
Physiol Genomics; 2008 Jul; 34(2):135-43. PubMed ID: 18460640
[TBL] [Abstract][Full Text] [Related]
10. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
11. Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus.
Holloway MG; Cui Y; Laz EV; Hosui A; Hennighausen L; Waxman DJ
Endocrinology; 2007 May; 148(5):1977-86. PubMed ID: 17317776
[TBL] [Abstract][Full Text] [Related]
12. GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.
Collin de l'Hortet A; Zerrad-Saadi A; Prip-Buus C; Fauveau V; Helmy N; Ziol M; Vons C; Billot K; Baud V; Gilgenkrantz H; Guidotti JE
Endocrinology; 2014 Jul; 155(7):2545-54. PubMed ID: 24708244
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.
Blaas L; Kornfeld JW; Schramek D; Musteanu M; Zollner G; Gumhold J; van Zijl F; Schneller D; Esterbauer H; Egger G; Mair M; Kenner L; Mikulits W; Eferl R; Moriggl R; Penninger J; Trauner M; Casanova E
Hepatology; 2010 Apr; 51(4):1319-26. PubMed ID: 20162728
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE
Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477
[TBL] [Abstract][Full Text] [Related]
16. GH/STAT5 signaling during the growth period in livers of mice overexpressing GH.
Martinez CS; Piazza VG; Díaz ME; Boparai RK; Arum O; Ramírez MC; González L; Becú-Villalobos D; Bartke A; Turyn D; Miquet JG; Sotelo AI
J Mol Endocrinol; 2015 Apr; 54(2):171-84. PubMed ID: 25691498
[TBL] [Abstract][Full Text] [Related]
17. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b).
Greenhalgh CJ; Bertolino P; Asa SL; Metcalf D; Corbin JE; Adams TE; Davey HW; Nicola NA; Hilton DJ; Alexander WS
Mol Endocrinol; 2002 Jun; 16(6):1394-406. PubMed ID: 12040024
[TBL] [Abstract][Full Text] [Related]
18. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
[TBL] [Abstract][Full Text] [Related]
20. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
